These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy. Kyhl K; Ahtarovski KA; Nepper-Christensen L; Ekström K; Ghotbi AA; Schoos M; Göransson C; Bertelsen L; Helqvist S; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; Clemmensen P; De Backer O; Høfsten DE; Køber L; Kelbæk H; Vejlstrup N; Lønborg J; Engstrøm T JACC Cardiovasc Interv; 2019 Apr; 12(8):721-730. PubMed ID: 31000010 [TBL] [Abstract][Full Text] [Related]
12. Design and rationale of the COMPLETE trial: A randomized, comparative effectiveness study of complete versus culprit-only percutaneous coronary intervention to treat multivessel coronary artery disease in patients presenting with ST-segment elevation myocardial infarction. Mehta SR; Wood DA; Meeks B; Storey RF; Mehran R; Bainey KR; Nguyen H; Bangdiwala SI; Cairns JA; Am Heart J; 2019 Sep; 215():157-166. PubMed ID: 31326681 [TBL] [Abstract][Full Text] [Related]
13. Percutaneous coronary intervention strategies in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease. Thomas MP; Bates ER Curr Opin Cardiol; 2017 Nov; 32(6):755-760. PubMed ID: 28759470 [TBL] [Abstract][Full Text] [Related]
14. Culprit vessel versus multivessel intervention at the time of primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction and multivessel disease: real-world analysis of 3984 patients in London. Iqbal MB; Ilsley C; Kabir T; Smith R; Lane R; Mason M; Clifford P; Crake T; Firoozi S; Kalra S; Knight C; Lim P; Malik IS; Mathur A; Meier P; Rakhit RD; Redwood S; Whitbread M; Bromage D; Rathod K; MacCarthy P; Dalby M; Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):936-43. PubMed ID: 25371542 [TBL] [Abstract][Full Text] [Related]
15. Fractional flow reserve-guided multivessel angioplasty in myocardial infarction: three-year follow-up with cost benefit analysis of the Compare-Acute trial. Smits PC; Laforgia PL; Abdel-Wahab M; Neumann FJ; Richardt G; Boxma-de Klerk B; Lunde K; Schotborgh CE; Piroth Z; Horak D; Wlodarczak A; Frederix GW; Omerovic E EuroIntervention; 2020 Jun; 16(3):225-232. PubMed ID: 32250250 [TBL] [Abstract][Full Text] [Related]
16. A comparison of multivessel and culprit vessel percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome patients with multivessel disease: a meta-analysis. Qiao Y; Li W; Mohamed S; Nie S; Du X; Zhang Y; Jia C; Wang X; Liu X; Ma C EuroIntervention; 2015 Sep; 11(5):525-32. PubMed ID: 26390516 [TBL] [Abstract][Full Text] [Related]
17. The assessment of non culprit coronary artery lesions in patients with ST segment elevated myocardial infarction and multivessel disease by control angiography with quantitative coronary angiography. Dönmez E; Koç M; Şeker T; İçen YK; Çayli M Int J Cardiovasc Imaging; 2016 Oct; 32(10):1471-6. PubMed ID: 27448213 [TBL] [Abstract][Full Text] [Related]
18. Meta-Analysis of Culprit-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease. Bangalore S; Toklu B; Stone GW Am J Cardiol; 2018 Mar; 121(5):529-536. PubMed ID: 29304995 [TBL] [Abstract][Full Text] [Related]
19. Prognosis of complete versus incomplete revascularisation of patients with STEMI with multivessel coronary artery disease: an observational study. Dimitriu-Leen AC; Hermans MP; Veltman CE; van der Hoeven BL; van Rosendael AR; van Zwet EW; Schalij MJ; Delgado V; Bax JJ; Scholte AJ Open Heart; 2017; 4(1):e000541. PubMed ID: 28409009 [TBL] [Abstract][Full Text] [Related]